SCP
BSTC

Seizert Capital Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Seizert Capital Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,312
Closed -$203K – 223
2020
Q2 		$203K Buy
+3,312
New +$192K 0.01% 189

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Seizert Capital Partners's BSTC Position: Q3 2020 in Review

Seizert Capital Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 3,312 shares — an estimated $203K sold.

Seizert Capital Partners first reported a position in BSTC in Q2 2020 and held it in 1 quarter. The position peaked at $203K in Q2 2020. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • Seizert Capital Partners reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • Seizert Capital Partners sold 3,312 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $203K.
  • Seizert Capital Partners first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 1 quarter.
  • Seizert Capital Partners's BioSpecifics Technologies Corp. position peaked at $203K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Seizert Capital Partners's 13F filing for Q3 2020, filed 3 Nov 2020.